229 related articles for article (PubMed ID: 24170166)
1. Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients.
Bodro M; Gudiol C; Garcia-Vidal C; Tubau F; Contra A; Boix L; Domingo-Domenech E; Calvo M; Carratalà J
Support Care Cancer; 2014 Mar; 22(3):603-10. PubMed ID: 24170166
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients.
Bodro M; Sabé N; Tubau F; Lladó L; Baliellas C; Roca J; Cruzado JM; Carratalà J
Transplantation; 2013 Nov; 96(9):843-9. PubMed ID: 23883973
[TBL] [Abstract][Full Text] [Related]
3. Frequency and clinical outcomes of ESKAPE bacteremia in solid organ transplantation and the risk factors for mortality.
Ye QF; Zhao J; Wan QQ; Qiao BB; Zhou JD
Transpl Infect Dis; 2014 Oct; 16(5):767-74. PubMed ID: 25124187
[TBL] [Abstract][Full Text] [Related]
4. Bacteremia due to ESKAPE pathogens: An emerging problem in cancer patients.
El-Mahallawy HA; Hassan SS; El-Wakil M; Moneer MM
J Egypt Natl Canc Inst; 2016 Sep; 28(3):157-62. PubMed ID: 27268592
[TBL] [Abstract][Full Text] [Related]
5. Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center.
Marín M; Gudiol C; Garcia-Vidal C; Ardanuy C; Carratalà J
Medicine (Baltimore); 2014 May; 93(3):143-149. PubMed ID: 24797169
[TBL] [Abstract][Full Text] [Related]
6. Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-β-lactamase-producing bacteria.
Frakking FN; Rottier WC; Dorigo-Zetsma JW; van Hattem JM; van Hees BC; Kluytmans JA; Lutgens SP; Prins JM; Thijsen SF; Verbon A; Vlaminckx BJ; Cohen Stuart JW; Leverstein-van Hall MA; Bonten MJ
Antimicrob Agents Chemother; 2013 Jul; 57(7):3092-9. PubMed ID: 23612198
[TBL] [Abstract][Full Text] [Related]
7. Microbiology and prevalence of E
de la Cruz-Hernández I; Cornejo-Juárez P; Tellez-Miranda O; Barrera-Pérez L; Sandoval-Hernández S; Vilar-Compte D; Velázquez-Acosta C; Volkow P
Am J Infect Control; 2020 Jan; 48(1):40-45. PubMed ID: 31395288
[TBL] [Abstract][Full Text] [Related]
8. Mortality Predictors in Acute Respiratory Distress Syndrome Renal Transplant Recipients With ESKAPE/rESKAPE Pneumonia.
Chu L; Ye QF; Wan QQ; Zhou JD
Transplant Proc; 2015 Oct; 47(8):2450-5. PubMed ID: 26518949
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteremia in an area with high endemicity.
To KK; Lo WU; Chan JF; Tse H; Cheng VC; Ho PL
Int J Infect Dis; 2013 Feb; 17(2):e120-4. PubMed ID: 23098812
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of children with carbapenem-resistant Acinetobacter baumannii bacteremia.
Vandepitte WP; Berge J; Andersson R
J Med Assoc Thai; 2014 Nov; 97 Suppl 11():S129-39. PubMed ID: 25509707
[TBL] [Abstract][Full Text] [Related]
12. Patterns of Drug-Resistant Bacteria in a General Hospital, China, 2011-2016.
Mao T; Zhai H; Duan G; Yang H
Pol J Microbiol; 2019; 68(2):225-232. PubMed ID: 31250593
[TBL] [Abstract][Full Text] [Related]
13. ETIOLOGY AND RESISTANCE PROFILE OF ISOLATED STRAINS FROM SEVERE SYSTEMIC INFECTIONS IN PATIENTS WITH IMMUNODEPRESSION--EXPERIENCE OF THE IASI INFECTIOUS DISEASES HOSPITAL 2011-2014.
Pleşca CE; Luca MC; Luca AS; Constantinescu S; Iancu LS
Rev Med Chir Soc Med Nat Iasi; 2015; 119(4):1141-6. PubMed ID: 26793861
[TBL] [Abstract][Full Text] [Related]
14. Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems.
Fukuchi T; Iwata K; Kobayashi S; Nakamura T; Ohji G
BMC Infect Dis; 2016 Aug; 16(1):427. PubMed ID: 27538488
[TBL] [Abstract][Full Text] [Related]
15. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome.
Ortega M; Marco F; Soriano A; Almela M; Martínez JA; Muñoz A; Mensa J
J Antimicrob Chemother; 2009 Mar; 63(3):568-74. PubMed ID: 19126669
[TBL] [Abstract][Full Text] [Related]
16. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia.
Tamma PD; Han JH; Rock C; Harris AD; Lautenbach E; Hsu AJ; Avdic E; Cosgrove SE;
Clin Infect Dis; 2015 May; 60(9):1319-25. PubMed ID: 25586681
[TBL] [Abstract][Full Text] [Related]
17. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
[TBL] [Abstract][Full Text] [Related]
18. Shifting trends and age distribution of ESKAPEEc resistance in bloodstream infection, Southwest China, 2012-2017.
Yang S; Xu H; Sun J; Sun S
Antimicrob Resist Infect Control; 2019; 8():61. PubMed ID: 30976388
[TBL] [Abstract][Full Text] [Related]
19. [Causative agents of intravenous catheter-related infections and their antibiotic susceptibilities].
Aktaş E; Sarı EN; Seremet Keskin A; Pişkin N; Külah C; Cömert F
Mikrobiyol Bul; 2011 Jan; 45(1):86-92. PubMed ID: 21341163
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial resistance of selected invasive bacteria in a tertiary care center: results of a prospective surveillance study.
Djuric O; Jovanovic S; Stosovic B; Tosic T; Jovanovic M; Markovic-Denic L
J Infect Dev Ctries; 2016 Dec; 10(12):1325-1331. PubMed ID: 28036312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
